PREEMPTIVE DOSING OF PLERIXAFOR GIVEN TO POOR STEM CELL MOBILIZERS ON DAY 5 OF G-CSF ADMINISTRATION

Plerixafor, given on day 4 of G-CSF treatment is more effective than G-CSF alone in mobilizing hematopoietic progenitor cells. We tested a strategy of preemptive plerixafor use following assessment of the peak mobilization response to 5 days of G-CSF. Patients were eligible for plerixafor if, on day...

Full description

Saved in:
Bibliographic Details
Main Authors: Horwitz, Mitchell E., Chute, John P., Gasparetto, Cristina, Long, Gwynn D., McDonald, Carolyn, Morris, Ashley, Rizzieri, David A., Sullivan, Keith M., Chao, Nelson J.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3877677/
https://ncbi.nlm.nih.gov/pubmed/22080963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.217
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items